PNOC Gene

PNOC Gene

Overview

PNOC Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PNOC Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PNOC</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PNOC</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=PNOC" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/obesity" style="color:#ef9a9a">Obesity</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">19 edges</a></td>
</tr>
</table>

PNOC encodes prepronociceptin, the precursor of nociceptin/orphanin FQ, a neuropeptide that signals through the NOP receptor (OPRL1).[@mollereau1994][@meunier1995] The PNOC-NOP system forms a distinct neuromodulatory axis with major roles in stress, pain, reward processing, arousal, and motor-circuit regulation.[@reinscheid1995][@toll2016]

In neurodegeneration, PNOC is a circuit and state modifier rather than a high-penetrance causative gene. Its relevance emerges through interactions with dopaminergic signaling, neuroinflammatory stress, sleep/circadian disruption, and non-motor symptom burden across disorders including [Parkinson's disease](/diseases/parkinsons-disease) and [Alzheimer's disease](/diseases/alzheimers-disease).[@toll2016][@ruzza2020]

Molecular Biology

PNOC is located on chromosome 8p21 and is transcribed as a propeptide that undergoes enzymatic cleavage to generate nociceptin and related fragments.[@mollereau1994][@reinscheid1995] Mature nociceptin acts on OPRL1, a Gi/o-coupled receptor that:
PMID: 23337899

• suppresses cAMP production,
• modulates calcium and potassium conductances,
• regulates neurotransmitter release in context-dependent ways.[@meunier1995][@reinscheid1995]

Systems Neuroscience Relevance

Stress and affective state control

PNOC [neurons](/entities/neurons) are integrated into limbic-hypothalamic circuits that couple stress salience to behavioral output. NOP signaling can buffer or amplify stress responses depending on region, timing, and stimulus type.[@toll2016][@leggio2017]

Pain and sensorimotor processing

PNOC-derived peptides influence spinal and supraspinal nociceptive processing and can produce antinociceptive or pronociceptive effects across models.[@reinscheid1995][@toll2016] This bidirectionality is clinically relevant because chronic pain frequently coexists with neurodegenerative disease.
PMID: 35275318

Basal ganglia and dopamine interactions

PNOC-NOP signaling modulates dopamine transmission in mesolimbic and nigrostriatal circuits.[@toll2016][@marti2005] This provides a mechanistic bridge to PD motor/non-motor phenotypes and to dyskinesia/adaptation processes under dopaminergic therapy.
PMID: 35838848

Disease-Oriented Interpretation

Parkinson's disease

Experimental evidence supports involvement of NOP signaling in basal ganglia output and motor-state modulation. NOP antagonism has shown anti-parkinsonian or anti-dyskinetic signals in selected preclinical and early translational studies.[@marti2005][@visanji2011] PNOC expression dynamics in human PD tissue remain incompletely resolved, but pathway plausibility is strong.
PMID: 37968732

Alzheimer's disease and cognitive decline

Direct PNOC genetics in AD are limited. However, nociceptin pathways intersect with stress biology, hippocampal synaptic plasticity, sleep regulation, and neuroinflammatory tone, each relevant to AD symptom progression and resilience.[@ruzza2020][@leggio2017]

Neuropsychiatric overlap

PNOC/NOP signaling has substantial evidence in anxiety, depression, and addiction circuits.[@toll2016][@witkin2019] Because neurodegeneration frequently includes neuropsychiatric syndromes, PNOC may contribute to symptom clusters even when not central to primary pathology.

Therapeutic Landscape

Drug development has explored both NOP agonists and antagonists:

• Agonist strategy: anxiolysis/analgesia concepts with reduced classic opioid liabilities in some paradigms.[@toll2016]
• Antagonist strategy: potential benefits for mood and selected motor outcomes, including PD-oriented translational work.[@visanji2011][@witkin2019]
• Mixed-profile compounds: ligands co-targeting NOP and opioid receptors for improved therapeutic index.[@kiguchi2020]

Experimental Priorities

• Define PNOC-cell and OPRL1-cell vulnerability maps in human PD/AD single-cell datasets.
• Pair CSF peptidomics with digital phenotyping of pain, sleep, and stress-reactivity trajectories.
• Test NOP modulation in combination with disease-modifying therapies to assess additive or antagonistic effects.

See Also

• [Parkinson's disease](/diseases/parkinsons-disease)](/proteins/parkin)
• [Alzheimer's disease](/diseases/alzheimers-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving PNOC Gene discovered through SciDEX knowledge graph analysis: